Cargando…
Retraction Note: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo
Autores principales: | Xu, Yu-Yin, Chen, Li, Wang, Gui-Lan, Zhou, Jia-Ming, Zhang, Yi-Xin, Wei, Yin-Ze, Zhu, Yuan-Yuan, Qin, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326930/ https://www.ncbi.nlm.nih.gov/pubmed/37420163 http://dx.doi.org/10.1186/s12885-023-11135-3 |
Ejemplares similares
-
A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo
por: Xu, Yu-Yin, et al.
Publicado: (2013) -
Retraction: HLA-B35 and dsRNA Induce Endothelin-1 via Activation of ATF4 in Human Microvascular Endothelial Cells
Publicado: (2020) -
Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats
por: Liu, Cheng, et al.
Publicado: (2022) -
Retraction Note: Reanalysis of the gene expression profile in chronic pancreatitis via bioinformatics methods
por: Yuan, Hang, et al.
Publicado: (2015) -
Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7
por: Zhang, Ruijie, et al.
Publicado: (2022)